I am a Medical Doctor with more than 24 years of broad and comprehensive clinical development experience, from both large Pharma as well as small biotech. During my 14 years in Clinical Development in Novo Nordisk I was part of the medical development teams within Trauma and Hemostasis, one of the programs being the medical lead on the CONTROL trial, phase 3, Trauma trial with rFVIIa. I also have 2 years of drug safety experience, mainly in the area of critical bleeds. My initial clinical experience was within internal medicine and cardiology.

Currently I am responsible for the phase 3 program in a small Danish Biotech, MinervaX, developing a maternal vaccine against Group B Streptococcus. Being in a small biotech requires broad skills, as here I need to cover all from safety, trial design to publications.

I am driven by improving treatment options for patients through new treatment modalities as well as other digital solutions across the board from clinical trials to treatment optimization. I am an ambitious team worker, setting high expectations for myself and my team and value working together towards common goals.